Skip to content

Geron GERN Return on equity

Return on equity at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
38.8%+7.3pp
Incyte logo
IncyteINCY
30.8%+30.4pp
Immunome logo
ImmunomeIMNM
-50.1%-10.8pp
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
-189.5%-8,509pp
Arcus Biosciences logo
Arcus BiosciencesRCUS
-70%+8.4pp
Celcuity logo
CelcuityCELC
-275.2%-990pp

Other financials

Income statement

See full
Revenue$51.8M+30.9%
Operating income$158.0K+101%
Net income-$3.6M+81.6%
EPS (diluted)-$0.01+66.7%

Balance sheet

See full
Cash & equivalents$48.7M-12.2%
Total debt$134.0M+10.0%
Total equity$229.1M-14.6%
Total assets$534.1M-5.0%

Cash flow

See full
Operating cash flow-$62.9M-31.1%
CapEx$206.0K+2.0%
Free cash flow-$43.8M-6.8%

Valuation

See full
Market cap$888.51M-7.6%
Enterprise value$973.78M-5.3%
P/S4.7×-174×

Profitability

See full
Operating margin-705.5%-351pp
Net margin-682.5%-339pp
FCF margin-734.4%-365pp

Returns & leverage

See full
Debt / equity0.6×+0.1×
Current ratio6.8×-1.1×

Where this comes from

Calculated from Geron’s reported figures.

Based on trailing twelve months.

The official record: Geron’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Geron's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Geron's return on equity?
Geron (GERN) reported return on equity of -27.1% in Q1 2026.
How has Geron's return on equity changed year-over-year?
Geron's return on equity increased by 40.3% year-over-year, from -45.3% to -27.1%.
What is the long-term trend for Geron's return on equity?
Over 5 years (2020 to 2025), Geron's return on equity has grown at a -5.5% compound annual growth rate (CAGR), from -43.7% to -33%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.